- 现金
- 62111 元
- 精华
- 26
- 帖子
- 30437
- 注册时间
- 2009-10-5
- 最后登录
- 2022-12-28
|
Characterization of the genotype and integration patterns of hepatitis B virus in early- and late-onset hepatocellular carcinoma
Hongli Yan1,3,†, Yuan Yang2,†, Ling Zhang1, Guannan Tang1, YuZhao Wang1, Geng Xue1, Weiping Zhou2 andShuhan Sun1,*
1 Department of Medical Genetics, Second Military Medical University, Shanghai, China
2 The Third Department of Hepatic Surgery, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, China
3 Department of Laboratory Medicine, Changhai Hospital, The Second Military Medical University, Shanghai, China
† These authors contributed equally to this article.
*Address reprint requests to: Shuhan Sun, M.D., Ph.D., Department of Medical Genetics, Second Military Medical University, 800 Xiangyin Road, Shanghai 200433, China. E-mail: [email protected]; fax: +86-21-81871053.
Article first published online: 18 MAR 2015
DOI: 10.1002/hep.27722
© 2015 by the American Association for the Study of Liver Diseases
I
Hepatology
Volume 61, Issue 6, pages 1821–1831, June 2015
This work was funded by the National Natural Science Foundation of China (No. 30801328, 81472770), Science Fund for Creative Research Groups (No. 81221061, 81201940), Shanghai Pujiang Project, and New Excellent Youth Plan (XYQ2013074) for financial support.
Early-onset hepatocellular carcinoma (HCC) accounts for 15%-20% of total HCC cases in Asia, and the incidence is increasing. The low frequency of cirrhosis and poor prognosis of early-onset HCC suggests that its mechanisms may differ from late-onset HCC. Although hepatitis B virus (HBV) infection is epidemiologically associated with HCC, the role of HBV in early-onset HCC remains poorly understood. Here, we report a comparative study of HBV subgenotypes and integration in early- (≤30) and late-onset (≥70) HBV-associated HCC using a novel high-throughput viral integration detection method. We report that HBV B2 is predominantly present in early-onset HCC. HBV integration is a common phenomenon, both in early- and late-onset HCC, which favors integrating into human repeat regions. Moreover, we found a breakpoint in 8q24 located between c-Myc and plasmocytoma variant translocation 1 (PVT1), which was detected in 12.4% (14 of 113) of early-onset HCCs, but only 1.4% (2 of 145) in late-onset HCCs. HBV integrating this site results in c-MYC, PVT1, and microRNA-1204 overexpression in tumors, thereby potentially contributing to the development of early-onset HCC. Conclusion: HBV genotype and integration patterns may be distinct in early-onset HCC. Our results may shed light on HCC risk factors in young HBV carriers. Further studies are needed to elucidate at which time in tumor development this integration event occurs and whether it plays an important, causative role in HCC development or progression. (Hepatology 2015;61:1821-1831)
|
|